| 價(jià)格 | ¥1260 | ¥2270 | ¥4300 |
| 包裝 | 5mg | 10mg | 25mg |
| 最小起訂量 | 5mg |
| 發(fā)貨地 | 上海 |
| 更新日期 | 2026-04-02 |
| 中文名稱(chēng):化合物 YM-155 hydrochloride | 英文名稱(chēng):YM-155 hydrochloride |
| CAS:355406-09-6 | 品牌: TargetMol |
| 產(chǎn)地: 美國(guó) | 保存條件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| 產(chǎn)品類(lèi)別: 抑制劑 | |
| 貨號(hào): T21834 |
| 名稱(chēng) | YM-155 hydrochloride |
| 描述 | Sepantronium hydrochloride (YM-155 hydrochloride) is a novel survivin suppressant that inhibits survivin promoter with an IC 50 of 0.54 nM[1]. |
| 體外活性 | Sepantronium bromide (YM155; 30 μM) is insensitive to survivn gene promoter-driven luciferase reporter activity. Sepantronium bromide shows significant supression on endogenous survivin expression in PC-3 and PPC-1 human HRPC cells with deficient p53 via transcriptional inhibition of the survivin gene promoter. Sepantronium bromide (100 nM) does not affect protein expression of c-IAP2, XIAP, Bcl-2, Bcl-xL, Bad, α-actin, and β-tubulin. Sepantronium bromide potently inhibits human cancer cell lines (mutated or truncated p53) such as PC-3, PPC-1, DU145, TSU-Pr1, 22Rv1, SK-MEL-5 and A375 with IC 50 s ranging from 2.3 to 11 nM, respectively [1]. Sepantronium bromide (YM155) resultin in an increase in sensitivity of NSCLC cells to γ-radiation. Sepantronium bromide combined with γ-radiation increases both the number of apoptotic cells and the activity of caspase-3. In addition, Sepantronium bromide delays the repair of radiation-induced double-strand breaks in nuclear DNA [2]. |
| 體內(nèi)活性 | Sepantronium bromide (YM155; 3 and 10 mg/kg) inhibits the tumor growth in PC-3 xenografts, without significant body weight loss and blood cell count reduction. Sepantronium bromide is highly distributed to tumor tissue in vivo. Sepantronium bromide shows 80% TGI at a dose of 5 mg/kg in PC-3 orthotopic xenografts [1]. Sepantronium bromide (YM155) in combination with γ-radiation shows potent antitumor activity against H460 or Calu6 xenografts in nude mice [2]. In this orthotopic renal and metastatic lung tumors models, Sepantronium bromide (YM-155) and IL-2 additively decreases tumor weight, lung metastasis, and luciferin-stained tumor images [3]. |
| 存儲(chǔ)條件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| 關(guān)鍵字 | YM-155 Hydrochloride | YM155 Hydrochloride | YM 155 hydrochloride |
| 相關(guān)產(chǎn)品 | Guanidine hydrochloride | Naringin | Enzalutamide | Aceglutamide | Alginic acid | Cysteamine hydrochloride | Hemin | Hydroxychloroquine | Sildenafil citrate | Stavudine | Tamoxifen | Paeonol |
| 成立日期 | 2013-04-18 (14年) | 注冊(cè)資本 | 566.265100萬(wàn)人民幣 |
| 員工人數(shù) | 100-500人 | 年?duì)I業(yè)額 | ¥ 1億以上 |
| 主營(yíng)行業(yè) | 天然產(chǎn)物,生化試劑,分子生物學(xué),分子砌塊,生物技術(shù)服務(wù) | 經(jīng)營(yíng)模式 | 貿(mào)易,工廠(chǎng),試劑,定制,服務(wù) |
| 產(chǎn)品名稱(chēng) | 價(jià)格 | 公司名稱(chēng) | 報(bào)價(jià)日期 | |
|---|---|---|---|---|
| 詢(xún)價(jià) |
VIP7年
|
上海澤葉生物科技有限公司
|
2026-06-05 | |
| 詢(xún)價(jià) |
湖北諾迪納生物技術(shù)有限公司
|
2025-04-23 | ||
| 詢(xún)價(jià) |
VIP5年
|
湖北魏氏化學(xué)試劑股份有限公司
|
2026-06-03 |